Transcript of "Asco breast--mammography-in-younger-women--palpation--account-for-many-diagnoses-in-michigan-study"
Vol. No. September 12, 2011CONFERENCE REPORTASCO Breast: Mammography in YoungerWomen, Palpation, Account for Many Diagnosesin Michigan StudyBy Dave Levitan | 12 de septiembre de 2011Controversy has swirled around breast cancer screening since the United States Preventive ServicesTask Force (USPSTF) changed its guidelines regarding mammography and breast exams in 2009.Though there is still disagreement, a new study presented at the American Society of Clinical Oncology(ASCO) Breast Cancer Symposium in San Francisco suggests that annual mammography and palpationof breast masses remain critical tools in early breast cancer diagnosis. Shown is a mammogram showing subtle cancerThe USPSTF now recommends biennial mammography—rather than annual, as before—for all womenbeginning only at age 50, with those aged 40 to 49 excluded from such screening. They also say thatevidence is insufficient to determine the utility of both mammography in women older than 75 years ofage, and of clinical breast exams in women aged 40 and older; the guidelines recommend againstteaching women breast self-examination.“We certainly know that younger women often have denser breast tissue, which can impact or reducethe sensitivity of mammography as compared to in older women, but certainly it doesn’t negate theutility of mammography as a screening test,” said Andrew Seidman, MD, an oncologist at MemorialSloan-Kettering Cancer Center in New York, during a press event before the symposium.In the new study that authors stress does not represent a screening population but a group who didpresent with a diagnosis of breast cancer, the majority of the 5,903-patient cohort was diagnosed prior tothe change in screening guidelines. A few, however, were recruited in November and December of2009. The cohort was a part of the Michigan Breast Oncology Quality Initiative (MiBOQI).Daniel Smith, a physician’s assistant student at Grand Valley State University who presented the study,said that 3,869 of the patients (65.5%) were diagnosed with mammography, and 1,759 were diagnosedusing palpation (29.8%); 90.2% of the latter were through a breast self-examination. A further 275patients’ cancer was detected with “other” methods, including axillary mass and breast pain, but thesewere excluded from the primary analyses.http://www.cancernetwork.com/conference-reports/asco2011/breast-cancer-symposium/content/articl 1e/10165/1947486
Vol. No. September 12, 2011The average age at diagnosis was 59.4 years. “Although the most frequently diagnosed group wasbetween 50 and 69, which was 51% of the sample . . . 26% were diagnosed under the age of 50,” Smithsaid. Patients diagnosed with mammography were older than those with palpable presentation (61.2years vs. 55.8 years, P = .001).Those cancers detected by mammography were also more likely to be early stage, with 25.1% and52.5% at stages 0 and I, respectively. For palpation, 29.2% and 50% were found at stage I and II,respectively. This may partially explain why palpation patients were more likely to undergo mastectomythan mammography patients (45.8% vs. 27.1%, P = .0001). Palpation patients also receivedchemotherapy more often than mammography patients (22.7% vs. 15.7%, P = .0001).Dr. Seidman, who was not involved with this research, noted that the use of screening in youngerwomen has led to lower rates of mastectomy and of chemotherapy because of earlier detection. “This isa very important gain, independent of any potential survival benefits,” he said. “Having less disfiguringsurgery and the ability to deliver less chemotherapy based on the stage at diagnosis, for me, is a stepforward.”It is difficult to say exactly how the changes in screening guidelines would have affected this cohort, butSmith did point out that 42.4% of the total sample was diagnosed either through a palpable presentationor mammography conducted in women under the age of 50.“Women who have breast cancer continue to present with palpable masses even in this contemporarycohort of patients,” said study co-author Jamie Caughran, MD, of Saint Mary’s Lacks Cancer Center inGrand Rapids, Michigan, during the press event. “We conclude that annual screening mammograms andevaluations of palpable breast masses are important tools in breast cancer detection.”http://www.cancernetwork.com/conference-reports/asco2011/breast-cancer-symposium/content/articl 2e/10165/1947486